Drug intelligence / Profile preview

GelStor

Development stage
Unknown
Lead developer
GelMEDIX
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic, Intracameral, Subconjunctival
01

Overview

GelStor is a bio-inspired, polyethylene glycol (PEG)-based hydrogel platform developed by GelMedix for the sustained delivery of ophthalmic therapeutics. The technology is designed to overcome the limitations of traditional eye drops, such as poor patient compliance and low bioavailability, by providing a long-lasting therapeutic depot. Upon administration via intracameral or subconjunctival injection, the hydrogel undergoes an in situ phase transition to form a solid, biodegradable matrix that slowly releases encapsulated active pharmaceutical ingredients (APIs) over several weeks or months. GelStor is being utilized in the development of treatments for post-operative inflammation, ocular pain, and glaucoma, offering a biocompatible and dissolvable solution for chronic ocular drug delivery.

Brand names
GelStor

Beyond the preview

Go deeper on GelStor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GelStor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call